|
00308
|
|
ADA ≥98.0% (T)
|
C6H10N2O5
|
|
|
|
|
459224
|
|
(S)-α-Amino-γ-butyrolactone hydrochloride 97%
|
C4H7NO2 · HCl
|
|
|
|
|
217700
|
|
DL-2-Aminocaprylic acid 99%
|
C8H17NO2
|
|
|
|
|
191140
|
|
7-Aminocephalosporanic acid 98%
|
C10H12N2O5S
|
|
|
|
|
A47109
|
|
4-Aminocinnamic acid hydrochloride predominantly trans, 97%
|
C9H9NO2 · HCl
|
|
|
|
|
438057
|
|
(S)-(+)-α-Aminocyclohexanepropionic acid hydrate technical grade
|
C9H17NO2 · xH2O
|
|
|
|
|
534927
|
|
(R)-Amino-(4-hydroxyphenyl)acetic acid methyl ester hydrochloride 97%
|
C9H11NO3 · HCl
|
|
|
|
|
08339
|
|
5-Aminolevulinic acid hydrochloride purum, ≥97.0% (AT)
|
C5H9NO3 · HCl
|
|
|
|
|
11585
|
|
4-Amino-nicotinic acid ≥97.0% (HPLC)
|
C6H6N2O2
|
|
|
|
|
335444
|
|
3-Aminophenylacetic acid 97%
|
C8H9NO2
|
|
|
|
|
A71352
|
|
4-Aminophenylacetic acid 98%
|
C8H9NO2
|
|
|
|
|
530255
|
|
2-Amino-2-phenylbutyric acid 96%
|
C10H13NO2
|
|
|
|
|
335339
|
|
4-(4-Aminophenyl)butyric acid 95%
|
C10H13NO2
|
|
|
|
|
50281
|
|
2-(4-Aminophenylthio)acetic acid ≥98.0%
|
C8H9NO2S
|
|
|
|
|
188808
|
|
DL-α-Amino-2-thiopheneacetic acid 97%
|
C6H7NO2S
|
|
|
|
|
123188
|
|
5-Aminovaleric acid 97%
|
C5H11NO2
|
|
|
|
|
09045
|
|
8-Benzyl (S)-2-aminooctanedioate ≥97.0%
|
C15H21NO4
|
|
|
|
|
15054
|
|
Boc-Aad-OH ≥98.0% (TLC)
|
C11H19NO6
|
|
|
|
|
17852
|
|
4-(Boc-amino)-1-methylpyrrole-2-carboxylic acid ≥99.0% (HPLC)
|
C11H16N2O4
|
|
|
|
|
66381
|
|
4-(Boc-amino)tetrahydrothiopyran-4-carboxylic acid ≥95.0% (TLC)
|
C11H19NO4S
|
|
|
|
|
695491
|
|
(1R,3S,4S)-N-Boc-2-azabicyclo[2.2.1]heptane-3-carboxylic acid 97%
|
C12H19NO4
|
|
|
|
|
78324
|
|
1-Boc-L-azetidine-2-carboxylic acid ≥98.0% (TLC)
|
C9H15NO4
|
|
|
|
|
09928
|
|
1-Boc-azetidine-3-carboxylic acid ≥98.0% (TLC)
|
C9H15NO4
|
|
|
|
|
90976
|
|
N-Boc-4-(Fmoc-amino)piperidine-4-carboxylic acid ≥97.0% (HPLC)
|
C26H30N2O6
|
|
|
|
|
15513
|
|
N-Boc-N′-Fmoc-diaminoacetic acid technical, ≥95.0% (HPLC)
|
C22H24N2O6
|
|
|
|
|
15518
|
|
Boc-Inp-OH ≥99.0% (HPLC)
|
C11H19NO4
|
|
|
|
|
89763
|
|
(R)-Boc-Nip-OH ≥97.0% (HPLC)
|
C11H19NO4
|
|
|
|
|
676322
|
|
(S)-1-Boc-4-oxopiperidine-2-carboxylic acid 95%
|
C11H17NO5
|
|
|
|
|
44264
|
|
2-(4-Boc-piperazino)-2-(4-fluorophenyl)acetic acid purum, ≥97.0% (HPLC)
|
C17H23FN2O4
|
|
|
|
|
16298
|
|
2-(4-Boc-piperazino)-2-phenylacetic acid purum, ≥97.0% (HPLC)
|
C17H24N2O4
|
|
|
|
|
680214
|
|
N-Boc-4-piperidineacetaldehyde 97%
|
C12H21NO3
|
|
|
|
|
81964
|
|
1-Boc-4-piperidylacetic acid ≥98.0% (TLC)
|
C12H21NO4
|
|
|
|
|
15397
|
|
Boc-Sta(3S,4S)-OH ~95% (sum of enantiomers, HPLC)
|
C13H25NO5
|
|
|
|
|
95471
|
|
(−)-Boc-L-thioproline puriss. p.a., for peptide synthesis, ≥99.0% (HPLC)
|
C9H15NO4S
|
|
|
|
|
15504
|
|
Boc-Tic-OH ≥97.0% (TLC)
|
C15H19NO4
|
|
|
|
|
15046
|
|
Boc-D-Tic-OH ≥97%
|
C15H19NO4
|
|
|
|
|
15451
|
|
Boc-Tle-OH ≥99.0% (T)
|
C11H21NO4
|
|
|
|
|
495018
|
|
1-(tert-Butoxycarbonyl)-3-piperidinecarboxylic acid 98%
|
C11H19NO4
|
|
|
|
|
861839
|
|
L-(+)-Canavanine sulfate salt monohydrate 98%
|
C5H12N4O3 · H2SO4 · H2O
|
|
|
|
|
22020
|
|
(±)-Carnitine hydrochloride purum, ≥99.0% (AT)
|
C7H16ClNO3
|
|
|
|
|
23125
|
|
Chlorambucil purum, ≥98.0% (T)
|
C14H19Cl2NO2
|
|
|
|
|
27510
|
|
L-Citrulline ≥99.0% (NT)
|
C6H13N3O3
|
|
|
|
|
33240
|
|
2,6-Diaminopimelic acid ≥97.0% (NT)
|
C7H14N2O4
|
|
|
|
|
D1377
|
|
2,6-Diaminopimelic acid ≥98% (TLC)
|
C7H14N2O4
|
|
|
|
|
D6796
|
|
meso-2,3-Diaminosuccinic acid
|
C4H8N2O4
|
|
|
|
|
218979
|
|
4-(Dimethylamino)cinnamic acid 99%
|
C11H13NO2
|
|
|
|
|
374032
|
|
4-(Dimethylamino)phenylacetic acid 97%
|
C10H13NO2
|
|
|
|
|
696404
|
|
Ethyl (S)-N-Boc-piperidine-3-carboxylate 95%
|
C13H23NO4
|
|
|
|
|
61897
|
|
Ethyl piperazinoacetate ≥95.0% (GC)
|
C8H16N2O2
|
|
|
|
|
47548
|
|
4-[2-(Fmoc-amino)ethyl]piperazin-1-ylacetic acid dihydrochloride ≥98.0% (HPLC)
|
C23H27N3O4 · 2HCl
|
|
|
|
|
93669
|
|
(R)-4-(Fmoc-amino)-5-phenylpentanoic acid ≥97.0%
|
C26H25NO4
|
|
|
|
|
70238
|
|
1-Fmoc-(S)-azetidine-2-carboxylic acid ≥97.0%
|
C19H17NO4
|
|
|
|
|
00398
|
|
1-Fmoc-azetidine-3-carboxylic acid ≥98.0% (HPLC)
|
C19H17NO4
|
|
|
|
|
17816
|
|
N-Fmoc-Freidinger’s lactam ≥95.0% (HPLC)
|
C24H26N2O5
|
|
|
|
|
93925
|
|
N-Fmoc-guvacine ≥96.0% (HPLC)
|
C21H19NO4
|
|
|
|
|
04059
|
|
Fmoc-Inp-OH ≥97.0% (HPLC)
|
C21H21NO4
|
|
|
|
|
84222
|
|
(R)-Fmoc-Nip-OH ≥99.0% (HPLC)
|
C21H21NO4
|
|
|
|
|
90233
|
|
Fmoc-DL-Nip-OH ≥99.0%
|
C21H21NO4
|
|
|
|
|
05519
|
|
Fmoc-4-phenyl-piperidine-4-carboxylic acid ≥97.0%
|
C27H25NO4
|
|
|
|
|
47553
|
|
4-Fmoc-1-piperazineacetic acid hydrate ≥97.0%
|
C21H22N2O4 · xH2O
|
|
|
|
|
47554
|
|
1-Fmoc-4-piperidineacetic acid ≥99.0% (HPLC)
|
C22H23NO4
|
|
|
|
|
706469
|
|
(R)-N-Fmoc-piperidine-2-carboxylic acid 97%
|
C21H21NO4
|
|
|
|
|
706434
|
|
(S)-N-Fmoc-piperidine-2-carboxylic acid 97%
|
C21H21NO4
|
|
|
|
|
00471
|
|
(R)-2-Fmoc-1,2,3,4-tetrahydronorharmane-3-carboxylic acid >97.0%
|
C27H22N2O4
|
|
|
|
|
03755
|
|
(S)-2-Fmoc-1,2,3,4-tetrahydronorharmane-3-carboxylic acid ≥98.0%
|
C27H22N2O4
|
|
|
|
|
47701
|
|
Fmoc-Tic-OH ≥97.0% (HPLC)
|
C25H21NO4
|
|
|
|
|
47437
|
|
Fmoc-D-Tic-OH ≥98.0% (TLC)
|
C25H21NO4
|
|
|
|
|
150568
|
|
(−)-Glutathione, oxidized
|
C20H32N6O12S2
|
|
|
|
|
220000
|
|
Iminodiacetic acid 98%
|
C4H7NO4
|
|
|
|
|
302244
|
|
Indoline-2-carboxylic acid 97%
|
C9H9NO2
|
|
|
|
|
61250
|
|
DL-Kynurenine ≥95.0% (NT)
|
C10H12N2O3
|
|
|
|
|
11558
|
|
Lithium L-aziridine-2-carboxylate ≥97.0% (dried material, NT)
|
C3H4LiNO2
|
|
|
|
|
07245
|
|
Methyl 4-aminobutyrate hydrochloride ≥99.0% (AT)
|
C5H11NO2 · HCl
|
|
|
|
|
03567
|
|
(S)-2-Piperazinecarboxylic acid dihydrochloride ≥98.0% (T)
|
C5H10N2O2 · 2HCl
|
|
|
|
|
728144
|
|
2-(1-Piperazinyl)acetic acid monohydrate ≥97% (TLC)
|
C6H12N2O2 · H2O
|
|
|
|
|
656356
|
|
(R)-(–)-3-Piperidinecarboxylic acid 97%
|
C6H11NO2
|
|
|
|
|
292915
|
|
2-Pyrrolidone-5-carboxylic acid 99%
|
C5H7NO3
|
|
|
|
|
422614
|
|
(R)-(+)-2-Pyrrolidone-5-carboxylic acid 95%
|
C5H7NO3
|
|
|
|
|
87433
|
|
(R)-1,2,3,4-Tetrahydro-3-isoquinolinecarboxylic acid ≥98.0% (T)
|
C10H11NO2
|
|
|
|
|
421626
|
|
(S)-1,2,3,4-Tetrahydro-3-isoquinolinecarboxylic acid 97%
|
C10H11NO2
|
|
|
|
|
88400
|
|
L-4-Thiazolidinecarboxylic acid purum, ≥99.0% (T)
|
C4H7NO2S
|
|
|
|
|
T27502
|
|
L-4-Thiazolidinecarboxylic acid 98%
|
C4H7NO2S
|
|
|
|
|
273449
|
|
(4R)-(−)-2-Thioxo-4-thiazolidinecarboxylic acid 99%
|
C4H5NO2S2
|
|
|
|
|
68972
|
|
Tri-Boc-hydrazinoacetic acid ≥97.0% (N)
|
C17H30N2O8
|
|
|
|
|
564605
|
|
3,3′,5-Triiodo-L-thyronine 95%
|
C15H12I3NO4
|
|
|
|
|
96720
|
|
Z-Tle-OH (dicyclohexylammonium) salt ≥99.0% (HPLC)
|
C14H19NO4 · C12H23N
|
|
|
|